Sweden

Pernilla Sandwall is an experienced life sciences executive and board member with more than 30 years of experience in pharmaceutical and biotech development.

She has held senior roles as CEO and COO in both privately owned and publicly listed companies, with strong expertise in clinical development, people leadership, and corporate governance. Pernilla brings long experience from the global pharma company Merck&Co/MSD, as well as hands-on leadership in the smaller innovation-driven life science companies.

She currently serves as a board member in MyCural Therapeutics, Clinical Trial Consultants and Modus Therapeutics, and previously served on the boards of Alzinova, LIF SME/IML and Pharmacists Without Borders.